TrialJournal of gastroenterology2018

Efficacy and safety of glecaprevir/pibrentasvir in Japanese patients with chronic genotype 1 hepatitis C virus infection with and without cirrhosis.

Kazuaki Chayama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.